Panobinostat/programmed cell death-1 receptor antagonistsDevelopment of resistance in merkel cell carcinoma: 3 case reports

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-019-64097-8
中图分类号
学科分类号
摘要
引用
收藏
页码:207 / 207
相关论文
共 50 条
  • [21] Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway
    Wang, Tianyu
    Wu, Xiaoxing
    Guo, Changying
    Zhang, Kuojun
    Xu, Jinyi
    Li, Zheng
    Jiang, Sheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (04) : 1715 - 1730
  • [23] Peroral cholangioscopy of programmed cell death-1 inhibitor-related sclerosing cholangitis: three case reports
    Onoyama, Takumi
    Takeda, Yohei
    Kato, Masayuki
    Edano, Mirai
    Tarumoto, Ryohei
    Matsumoto, Kazuya
    Isomoto, Hajime
    ENDOSCOPY, 2019, 51 (12) : E402 - E403
  • [24] Hairy cell leukemia expresses programmed death-1
    Kumar, Priyadarshini
    Gao, Qi
    Chan, Alexander
    Lewis, Natasha
    Sigler, Allison
    Pichardo, Janine
    Xiao, Wenbin
    Roshal, Mikhail
    Dogan, Ahmet
    BLOOD CANCER JOURNAL, 2020, 10 (11)
  • [25] Hairy cell leukemia expresses programmed death-1
    Priyadarshini Kumar
    Qi Gao
    Alexander Chan
    Natasha Lewis
    Allison Sigler
    Janine Pichardo
    Wenbin Xiao
    Mikhail Roshal
    Ahmet Dogan
    Blood Cancer Journal, 10
  • [26] Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma
    Chen, Kaiyan
    Cheng, Guoping
    Zhang, Fanrong
    Zhang, Nan
    Li, Dan
    Jin, Jiaoyue
    Wu, Junzhou
    Ying, Lisha
    Mao, Weimin
    Su, Dan
    ONCOTARGET, 2016, 7 (21) : 30772 - 30780
  • [30] Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action
    Zhang, Ni
    Tu, Jingyao
    Wang, Xue
    Chu, Qian
    IMMUNOTHERAPY, 2019, 11 (05) : 429 - 441